NEW YORK (

TheStreet

) --

BioMimetic Therapeutics

(Nasdaq:

BMTI

) is trading at unusually high volume Friday with 3.3 million shares changing hands. It is currently at 10.8 times its average daily volume and trading down 52 cents (-5.7%) at $8.68 as of 10:11 a.m. ET.

BioMimetic has a market cap of $257.5 million and is part of the

health care

sector and

health services

industry. Shares are down 27.6% year to date as of the close of trading on Thursday.

BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage.

TheStreet Ratings rates BioMimetic as a

TheStreet Recommends

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full

BioMimetic Ratings Report

.

See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center

.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting

HVDOWN

to 95370 or select from

multiple alert options

.

null